Insulin, Isophane clinical trials
A group of medicines. Isophane Insulin, Human (6 studies) is counted on its own page; this page counts the studies that name Insulin, Isophane itself.
Counted the way a researcher would: Insulin, Isophane with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Insulin, Isophane is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Insulin, Isophane studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Medicines filed under Insulin, Isophane
As reviewed, so not every one. Each counts its studies on its own page, not here.
Studies by the year they started
33 studies that test it; most in 2003 (5)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 16
Novo Nordisk A/S (14) · Inova Health Care Services (2) · Shifa International Hospital (1) · Universidad de Guanajuato (1) · Geropharm (1) · Norwegian University of Science and Technology (1) · Hennepin Healthcare Research Institute (1) · Washington University School of Medicine (1)
Often tested with
Tested in the same studies.
Insulin Detemir (10) · Insulin Glargine (8) · Insulin Aspart (7) · Insulin, Regular, Human (3) · Sitagliptin (2) · Repaglinide (2) · Metformin (1) · Biphasic human insulin 30 (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Insulin, Isophane.
- Jan 2027Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 DiabetesPhase 1/2 · Shifa International Hospital
Studies
Open first, then newest update. How each study uses Insulin, Isophane is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 33
- RCT Glargine vs NPH for Treatment of DM in PregnancyRecruitingPhase 3Loyola UniversityNCT06619301Written as insulin NPHHow we know
- Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 DiabetesActive, not recruitingPhase 1/2Shifa International HospitalNCT07757464Written as Insulin Isophane Human, NPH, Pre-emptive AlgorithmHow we know
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00504673Written as insulin NPHHow we know
- Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.CompletedPhase 3Novo Nordisk A/SNCT00476437Written as biphasic human insulinHow we know
- Comparison of Insulin Therapy in Treating Post-Transplant DiabetesTerminatedPhase 4Inova Health Care ServicesNCT01963728Written as Insulin, IsophaneHow we know
- Insulin Schemes for Type 2 Diabetes ControlCompletedPhase 4Universidad de GuanajuatoNCT03350984Written as NPH insulinHow we know
- Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.Status unknownPhase 4Ain Shams UniversityNCT04664764Written as NPH insulinHow we know
- Use of NPH Versus Basal Bolus Insulin for Steroid Induced HyperglycemiaTerminatedPhase 4Northwestern UniversityNCT03511521Written as NPH InsulinHow we know
- Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp MethodCompletedNot applicableGeropharmNCT04501250Written as Humulin NPHHow we know
- Treatment of Latent Autoimmune Diabetes of the AdultCompletedNot applicableNorwegian University of Science and TechnologyNCT01140438Written as metformin+ NPH insulinHow we know
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPHTerminatedNot applicableUniversity of Texas Southwestern Medical CenterNCT00564018Written as NPHHow we know
- Inpatient Diabetes on CorticosteroidsCompletedPhase 4Hennepin Healthcare Research InstituteNCT01970241Written as NPHHow we know
- A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal InsulinTerminatedPhase 3Novo Nordisk A/SNCT02131272Written as Insulin NPHHow we know
- Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology PatientsCompletedEarly Phase 1Washington University School of MedicineNCT02012465Written as Insulin protocolHow we know
- Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00435019Written as insulin NPHHow we know
- Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00595374Written as insulin NPHHow we know
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00617565Written as biphasic human insulinHow we know
- Safety of Insulin Detemir in Children With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00605137Written as insulin NPHHow we know
- Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT00799448Written as insulin NPHHow we know
- The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized PatientsCompletedPhase 4Baylor College of MedicineNCT01810952Written as NPH InsulinHow we know
See all 33 studies that test Insulin, Isophane →
Given beside what is tested · 11 — Insulin, Isophane is usual care or a partner of the new treatment
- A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCompletedPhase 1SanofiNCT02910518Written as NPH insulinHow we know
- Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesCompletedPhase 2Sansum Diabetes Research InstituteNCT01662921Written as NPHHow we know
- Effect of Insulin Detemir on Use of Energy in Type 1 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT00509925Written as insulin NPHHow we know
- Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00832182Written as insulin NPHHow we know
- Safety and Efficacy of Insulin Aspart in Children With Type 1 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01467141Written as isophane human insulinHow we know
- Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01720303Written as isophane human insulinHow we know
- Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01562561Written as insulin NPHHow we know
- Pharmacokinetics of Insulin Detemir in Subjects With Type 1 DiabetesCompletedPhase 1Novo Nordisk A/SNCT01542450Written as insulin NPHHow we know
- Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedPhase 1Novo Nordisk A/SNCT01497600Written as insulin NPHHow we know
- Safety and Efficacy of Insulin Aspart in Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01707134Written as insulin NPHHow we know
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCompletedPhase 3SanofiNCT00115570Written as NPH insulinHow we know
As the comparator · 26 — what is tested is compared with Insulin, Isophane
- DETERMINE: Detemir vs NPHRecruitingPhase 2University of California, Los AngelesNCT05124457Written as Insulin NPHHow we know
- Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT00506662Written as insulin NPHHow we know
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinCompletedPhase 4SanofiNCT02967224Written as NPH insulinHow we know
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinCompletedPhase 4SanofiNCT02967211Written as NPH insulinHow we know
- Toujeo Versus NPH Self-titration StudyCompletedPhase 4Elaine ChowNCT03389490Written as Neutral protamine hagedorn insulinHow we know
- Glargine Versus NPH in Patients With Chronic Kidney DiseaseCompletedPhase 4University of Sao Paulo General HospitalNCT02451917Written as NPH insulinHow we know
- Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.CompletedPhase 3Novo Nordisk A/SNCT03220425Written as NPH insulinHow we know
- Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTerminatedPhase 4Novo Nordisk A/SNCT01486966Written as insulin NPHHow we know
- Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00474045Written as NPH insulinHow we know
- Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01467401Written as biphasic human insulinHow we know
- Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01697657Written as insulin NPHHow we know
- Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01486940Written as insulin NPHHow we know
- Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 DiabetesCompletedPhase 1Novo Nordisk A/SNCT01497561Written as insulin NPHHow we know
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT01467323Written as biphasic human insulinHow we know
- Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin TreatmentCompletedPhase 4Novo Nordisk A/SNCT00795600Written as insulin NPHHow we know
- Insulin Therapy for Post-transplant Glucocorticoid Induced HyperglycemiaTerminatedPhase 4Vancouver General HospitalNCT01648218Written as Neutral protamine hagedorn (NPH) insulinHow we know
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin DegludecCompletedPhase 1Novo Nordisk A/SNCT01865279Written as isophane human insulinHow we know
- Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 DiabetesCompletedPhase 2Novo Nordisk A/SNCT00660374Written as insulin NPHHow we know
- Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 DiabetesCompletedPhase 2Novo Nordisk A/SNCT00698802Written as biphasic human insulinHow we know
- Insulin Detemir Versus NPH Insulin In Hospitalized Patients With DiabetesCompletedPhase 4Emory UniversityNCT00590226Written as NPH insulin + regular insulinHow we know
Showing 20 of 26.
Codes
What other systems call Insulin, Isophane · ClinicalTrials.gg INT007668
- MeSH (NLM) D007336Insulin, IsophaneOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007336 | Insulin, Isophane | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.